Showing results (61-70 of 148) with videos related to
Sort By:
Pageof 15
Leukemia|March 1, 1987
Cytotoxicity and differentiating actions of adriamycin in WEHI-3B D+ leukemia cellsC Gamba-Vitalo, O C Blair, T R Tritton, et al.Cancer Communications|January 1, 1989
Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistanceJ A Posada, E M McKeegan, K F Worthington, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1977
Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniquesL B Lachman, M P Hacker, R E HandschumacherToxicology and Applied Pharmacology|September 30, 1983
Fibrogenic structure-activity study of the bleomycin moleculeR A Newman, M P Hacker, T T SakaiToxicology and Applied Pharmacology|September 15, 1989
Effect of cytotoxic monoclonal antibody depletion of T-lymphocyte subpopulations on bleomycin-induced lung damage in C57BL/6J miceD Janick-Buckner, G E Ranges, M P HackerBiochemical Pharmacology|September 28, 1995
Comparison of aza-anthracenedione-induced DNA damage and cytotoxicity in experimental tumor cellsL A Hazlehurst, A P Krapcho, M P HackerToxicology and Applied Pharmacology|June 15, 1983
The effect of L-3, 4-dehydroproline on the antitumor activity and toxicity of bleomycinM P Hacker, R A Newman, C B HongCancer Research|September 1, 1981
Amelioration of adriamycin and daunorubicin myocardial toxicity by adenosineR A Newman, M P Hacker, I H KrakoffCancer Research|April 15, 1990
Effect of erythrocytes on alveolar macrophage cytostatic activity induced by bleomycin lung damage in ratsA E Huot, R M Gundel, M P HackerBiochemical Pharmacology|November 16, 2001
Impact of the basic amine on the biological activity and intracellular distribution of an aza-anthrapyrazole: BBR 3422K M Chou, A Paul Krapcho, M P HackerPageof 15